Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
27 01 2020
Historique:
received: 12 06 2019
revised: 01 08 2019
accepted: 20 08 2019
pubmed: 31 12 2019
medline: 6 10 2020
entrez: 30 12 2019
Statut: ppublish

Résumé

The aim of this study was to evaluate and compare the outcomes of transcatheter self-expandable prostheses in patients with small annuli. Transcatheter aortic heart valves appear to have better performance than surgical valves in terms of prosthesis-patient mismatch, especially in patients with aortic stenosis with small aortic annuli. TAVI-SMALL (International Multicenter Registry to Evaluate the Performance of Self-Expandable Valves in Small Aortic Annuli) is a retrospective registry of patients with severe aortic stenosis and small annuli (annular perimeter <72 mm or area <400 mm Pre-discharge gradients were consistently low in every group, with a slight benefit with the Evolut R (8.1 mm Hg; 95% confidence interval [CI]: 7.7 to 8.5 mm Hg) and Evolut PRO (6.9 mm Hg; 95% CI: 6.3 to 7.6 mm Hg) compared with the ACURATE (9.6 mm Hg; 95% CI: 8.9 to 10.2 mm Hg) and Portico (8.9 mm Hg; 95% CI: 8.2 to 9.6 mm Hg) groups (p < 0.001). Mean indexed effective orifice area was 1.04 cm Transcatheter self-expandable valves showed optimal clinical and echocardiographic results in patients with small aortic annuli, although supra-annular functioning transcatheter heart valves seemed to slightly outperform intra-annular functioning ones. The role of transcatheter aortic valve replacement with self-expandable valves for the treatment of aortic stenosis in patients with small annuli needs to be confirmed in larger trials.

Sections du résumé

OBJECTIVES
The aim of this study was to evaluate and compare the outcomes of transcatheter self-expandable prostheses in patients with small annuli.
BACKGROUND
Transcatheter aortic heart valves appear to have better performance than surgical valves in terms of prosthesis-patient mismatch, especially in patients with aortic stenosis with small aortic annuli.
METHODS
TAVI-SMALL (International Multicenter Registry to Evaluate the Performance of Self-Expandable Valves in Small Aortic Annuli) is a retrospective registry of patients with severe aortic stenosis and small annuli (annular perimeter <72 mm or area <400 mm
RESULTS
Pre-discharge gradients were consistently low in every group, with a slight benefit with the Evolut R (8.1 mm Hg; 95% confidence interval [CI]: 7.7 to 8.5 mm Hg) and Evolut PRO (6.9 mm Hg; 95% CI: 6.3 to 7.6 mm Hg) compared with the ACURATE (9.6 mm Hg; 95% CI: 8.9 to 10.2 mm Hg) and Portico (8.9 mm Hg; 95% CI: 8.2 to 9.6 mm Hg) groups (p < 0.001). Mean indexed effective orifice area was 1.04 cm
CONCLUSIONS
Transcatheter self-expandable valves showed optimal clinical and echocardiographic results in patients with small aortic annuli, although supra-annular functioning transcatheter heart valves seemed to slightly outperform intra-annular functioning ones. The role of transcatheter aortic valve replacement with self-expandable valves for the treatment of aortic stenosis in patients with small annuli needs to be confirmed in larger trials.

Identifiants

pubmed: 31883714
pii: S1936-8798(19)31866-7
doi: 10.1016/j.jcin.2019.08.041
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

196-206

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Damiano Regazzoli (D)

Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy. Electronic address: damiano.regazzoli@gmail.com.

Mauro Chiarito (M)

Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Francesco Cannata (F)

Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Matteo Pagnesi (M)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.

Mizuki Miura (M)

Heart Center, Zürich University Hospital, University of Zürich, Zürich, Switzerland.

Francesca Ziviello (F)

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Andrea Picci (A)

Cardiologia, Centro Alte Specialità e Trapianti, Policlinico Vittorio Emanuele, Università di Catania, Catania, Italy.

Jörg Reifart (J)

Department of Cardiology and Cardiac Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.

Federico De Marco (F)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Francesco Bedogni (F)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Marianna Adamo (M)

Civil Hospital and University of Brescia, Brescia, Italy.

Salvatore Curello (S)

Civil Hospital and University of Brescia, Brescia, Italy.

Rui Teles (R)

Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal.

Maurizio Taramasso (M)

Heart Center, Zürich University Hospital, University of Zürich, Zürich, Switzerland.

Marco Barbanti (M)

Cardiologia, Centro Alte Specialità e Trapianti, Policlinico Vittorio Emanuele, Università di Catania, Catania, Italy.

Corrado Tamburino (C)

Cardiologia, Centro Alte Specialità e Trapianti, Policlinico Vittorio Emanuele, Università di Catania, Catania, Italy.

Giulio G Stefanini (GG)

Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.

Antonio Mangieri (A)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; GVM Care and Research, Maria Cecilia Hospital, Ravenna, Italy.

Francesco Giannini (F)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; GVM Care and Research, Maria Cecilia Hospital, Ravenna, Italy.

Paolo A Pagnotta (PA)

Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy.

Francesco Maisano (F)

Heart Center, Zürich University Hospital, University of Zürich, Zürich, Switzerland.

Won-Keun Kim (WK)

Department of Cardiology and Cardiac Surgery, Kerckhoff Heart and Lung Center, Bad Nauheim, Germany.

Nicolas M Van Mieghem (NM)

Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands.

Antonio Colombo (A)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; GVM Care and Research, Maria Cecilia Hospital, Ravenna, Italy.

Bernhard Reimers (B)

Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy.

Azeem Latib (A)

Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy; Division of Cardiology, Montefiore Medical Center, Bronx, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH